Diversity in Pancreatic Cancer Clinical Trials Remains Low
Diversity within pancreatic cancer clinical trials has not improved over the past 15 years, according to a new study published in Gastroenterology.
Researchers from the...
Hem/Onc Roundup: BCMA CAR T Approved for MM, Disparities Remain in Breast Cancer Screening
This week, the U.S. FDA approved idecabtagene vicleucel (ide-cel) for the treatment of adults with relapsed/refractory multiple myeloma following four or more previous treatments....
Surgery Viable Treatment for Pancreatic Cancer Patients Following Chemotherapy
Surgery is an underused, and viable treatment option for patients with stage II pancreatic cancer, according to a study published in the Journal of...
Second-Line Therapy Outcomes in Metastatic Pancreatic Cancer
A study published in ESMO Open evaluated outcomes of second-line chemotherapy combinations for patients with metastatic pancreatic cancer who had failed on first-line treatments.
“There...
Case Study: Impact of COVID-19 on Pancreatic Cancer Surgery Outcomes
A study published in In Vivo evaluated the impact of COVID-19 infection on postoperative outcomes in patients with pancreatic cancer.
The case study included three...
Hem/Onc Roundup: Eliminating Disparity in MM Trials; Plus, Cancer Care in the Pandemic
This week, researchers from the Dana-Farber Cancer Institute collaborated with the U.S. Food and Drug Administration (FDA) and the American Association for Cancer Research...
Pancreatic Cancer Mortality Predicted to Rise Among Women
Rates of mortality due to pancreatic cancer were not predicted to improve across Europe in 2021, and may even increase among women, according to...
